Safely Omitting Basal Insulin in Type 2 Diabetes Management
Introduction to Basal Insulin Omission
- The American Diabetes Association recommends considering insulin primarily when HbA1c is very high (≥9.0%) or when patients present with severe hyperglycemia, suggesting that patients with well-controlled type 2 diabetes may safely omit basal insulin 5, 6
- Patients with type 2 diabetes who are not insulin-deficient can often maintain adequate glycemic control with oral medications, such as metformin and sulfonylureas, which address complementary mechanisms of action - reducing hepatic glucose production and enhancing insulin secretion 1, 2, 4
Assessment and Monitoring
- After discontinuing basal insulin, close monitoring of blood glucose levels is essential, particularly fasting glucose, to ensure that glycemic control is maintained 2, 3
- HbA1c should be checked within 3 months to ensure maintenance of glycemic control, with a target HbA1c level depending on individual patient factors and guidelines from organizations such as the American Diabetes Association 2, 6
Benefits and Risks of Basal Insulin Discontinuation
- Discontinuing basal insulin can reduce the risk of hypoglycemia, simplify the medication regimen, and potentially improve quality of life by eliminating insulin injections 1, 2, 3, 7
- However, there is a potential for deterioration in glycemic control, as type 2 diabetes is a progressive disease, and close monitoring for signs of inadequate control is necessary 1, 4, 5
Decision-Making Algorithm
- The decision to discontinue basal insulin should be based on current HbA1c level, with discontinuation likely safe if HbA1c is <7.5%, and consideration of a trial of discontinuation with close monitoring if HbA1c is 7.5-8.5% 1, 4
- Fasting blood glucose should be monitored daily for the first 2 weeks after discontinuation, and then 2-3 times weekly thereafter if readings are stable, with return to insulin if fasting glucose consistently exceeds target levels 2, 5